Literature DB >> 23266960

XCIND as a genetic disease of X-irradiation hypersensitivity and cancer susceptibility.

Shuki Mizutani1, Masatoshi Takagi.   

Abstract

The XCIND syndrome is named after distinct hypersensitivity to ionizing (X-ray) irradiation, cancer susceptibility, immunodeficiency, neurological abnormality, and double-strand DNA breakage. The disorders comprising XCIND syndrome are usually inherited in an autosomal recessive manner. Ataxia telangiectasia (A-T) is one such disease, and is caused by biallelic germline mutation of the Ataxia telangiectasia mutated (ATM) gene. Heterozygous carriers of the ATM mutation, who do not show A-T-like clinical symptoms, are estimated to comprise 1 % of the population. Thus, understanding the biological basis of XCIND, including A-T, should help shed light on the pathogenesis of genetic diseases with cancer susceptibility.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23266960     DOI: 10.1007/s12185-012-1240-5

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  26 in total

Review 1.  Initiating cellular stress responses.

Authors:  Christopher J Bakkenist; Michael B Kastan
Journal:  Cell       Date:  2004-07-09       Impact factor: 41.582

Review 2.  Beyond ATM: the protein kinase landscape of the DNA damage response.

Authors:  Ariel Bensimon; Ruedi Aebersold; Yosef Shiloh
Journal:  FEBS Lett       Date:  2011-05-08       Impact factor: 4.124

3.  Assessing 'radiosensitivity' with kinetic profiles of γ-H2AX, 53BP1 and BRCA1 foci.

Authors:  Nathan T Martin; Shareef A Nahas; Rashmi Tunuguntla; Francesca Fike; Richard A Gatti
Journal:  Radiother Oncol       Date:  2011-06-30       Impact factor: 6.280

4.  The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder.

Authors:  G S Stewart; R S Maser; T Stankovic; D A Bressan; M I Kaplan; N G Jaspers; A Raams; P J Byrd; J H Petrini; A M Taylor
Journal:  Cell       Date:  1999-12-10       Impact factor: 41.582

5.  DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.

Authors:  Jirina Bartkova; Zuzana Horejsí; Karen Koed; Alwin Krämer; Frederic Tort; Karsten Zieger; Per Guldberg; Maxwell Sehested; Jahn M Nesland; Claudia Lukas; Torben Ørntoft; Jiri Lukas; Jiri Bartek
Journal:  Nature       Date:  2005-04-14       Impact factor: 49.962

Review 6.  p53 and ATM: cell cycle, cell death, and cancer.

Authors:  S E Morgan; M B Kastan
Journal:  Adv Cancer Res       Date:  1997       Impact factor: 6.242

7.  ATM-deficient thymic lymphoma is associated with aberrant tcrd rearrangement and gene amplification.

Authors:  Shan Zha; Craig H Bassing; Takaomi Sanda; James W Brush; Harin Patel; Peter H Goff; Michael M Murphy; Suprawee Tepsuporn; Richard A Gatti; A Thomas Look; Frederick W Alt
Journal:  J Exp Med       Date:  2010-06-21       Impact factor: 14.307

Review 8.  The clinical manifestation of a defective response to DNA double-strand breaks as exemplified by Nijmegen breakage syndrome.

Authors:  I Demuth; M Digweed
Journal:  Oncogene       Date:  2007-12-10       Impact factor: 9.867

Review 9.  Leukemia and lymphoma in ataxia telangiectasia.

Authors:  A M Taylor; J A Metcalfe; J Thick; Y F Mak
Journal:  Blood       Date:  1996-01-15       Impact factor: 22.113

10.  RIDDLE immunodeficiency syndrome is linked to defects in 53BP1-mediated DNA damage signaling.

Authors:  Grant S Stewart; Tatjana Stankovic; Philip J Byrd; Thomas Wechsler; Edward S Miller; Aarn Huissoon; Mark T Drayson; Stephen C West; Stephen J Elledge; A Malcolm R Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-16       Impact factor: 11.205

View more
  9 in total

1.  DNA damage response and disorders with hematology, oncology and immunology.

Authors:  Shuki Mizutani
Journal:  Int J Hematol       Date:  2017-07-11       Impact factor: 2.490

Review 2.  Recent advances in the study of immunodeficiency and DNA damage response.

Authors:  Tomohiro Morio
Journal:  Int J Hematol       Date:  2017-05-26       Impact factor: 2.490

3.  Application of a radiosensitivity flow assay in a patient with DNA ligase 4 deficiency.

Authors:  David Buchbinder; Matthew J Smith; Misako Kawahara; Morton J Cowan; Jeffrey S Buzby; Roshini S Abraham
Journal:  Blood Adv       Date:  2018-08-14

4.  Identification of ATIC as a Novel Target for Chemoradiosensitization.

Authors:  Xiangfei Liu; Uma Devi Paila; Sharon N Teraoka; Jocyndra A Wright; Xin Huang; Aaron R Quinlan; Richard A Gatti; Patrick Concannon
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-09-21       Impact factor: 7.038

5.  Novel Combined Immune Deficiency and Radiation Sensitivity Blended Phenotype in an Adult with Biallelic Variations in ZAP70 and RNF168.

Authors:  Ivan K Chinn; Robert P Sanders; Asbjørg Stray-Pedersen; Zeynep H Coban-Akdemir; Vy Hong-Diep Kim; Harjit Dadi; Chaim M Roifman; Troy Quigg; James R Lupski; Jordan S Orange; I Celine Hanson
Journal:  Front Immunol       Date:  2017-05-26       Impact factor: 7.561

Review 6.  Exploration of genetic basis underlying individual differences in radiosensitivity within human populations using genome editing technology.

Authors:  Tatsuo Miyamoto; Silvia Natsuko Akutsu; Hiroshi Tauchi; Yoshiki Kudo; Satoshi Tashiro; Takashi Yamamoto; Shinya Matsuura
Journal:  J Radiat Res       Date:  2018-04-01       Impact factor: 2.724

Review 7.  Ionizing Radiation Protein Biomarkers in Normal Tissue and Their Correlation to Radiosensitivity: Protocol for a Systematic Review.

Authors:  Anne Dietz; Maria Gomolka; Simone Moertl; Prabal Subedi
Journal:  J Pers Med       Date:  2020-12-22

8.  Evaluation of ATM heterozygous mutations underlying individual differences in radiosensitivity using genome editing in human cultured cells.

Authors:  Ekaterina Royba; Tatsuo Miyamoto; Silvia Natsuko Akutsu; Kosuke Hosoba; Hiroshi Tauchi; Yoshiki Kudo; Satoshi Tashiro; Takashi Yamamoto; Shinya Matsuura
Journal:  Sci Rep       Date:  2017-07-20       Impact factor: 4.379

9.  Comparison of Selected Parameters of Redox Homeostasis in Patients with Ataxia-Telangiectasia and Nijmegen Breakage Syndrome.

Authors:  Barbara Pietrucha; Edyta Heropolitanska-Pliszka; Mateusz Maciejczyk; Halina Car; Jolanta Sawicka-Powierza; Radosław Motkowski; Joanna Karpinska; Marta Hryniewicka; Anna Zalewska; Malgorzata Pac; Beata Wolska-Kusnierz; Ewa Bernatowska; Bozena Mikoluc
Journal:  Oxid Med Cell Longev       Date:  2017-12-31       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.